GRI Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This report covers the 2024 Annual Meeting of Stockholders held by GRI Bio, Inc. on August 23, 2024. The filing details the voting results and the subsequent adjournment of the meeting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
- Quorum Status: A quorum was established with 256,566 shares present or represented by proxy, representing approximately 34.58% of the 741,914 shares entitled to vote.
- Adjournment Proposal: The sole matter voted upon was the proposal to adjourn the meeting to solicit additional proxies. The proposal was approved with 157,455 votes for, 99,095 votes against, and 16 abstentions.
- Meeting Status: Following the vote, the Annual Meeting was adjourned to Friday, September 6, 2024, at 11:00 a.m. Eastern Time, to be held virtually.
Outlook and Management Commentary
Management adjourned the meeting to allow for the solicitation of additional proxies necessary to adopt the remaining proposals set forth in the Proxy Statement. No specific financial guidance or risk factors were disclosed in this specific filing.
Key Facts for Investor Verification
- Verify the specific proposals that failed to pass at the initial meeting and require a vote at the September 6, 2024 adjourned session.
- Review the Definitive Proxy Statement (dated August 2, 2024) for details on the remaining business items.
- Monitor the outcome of the adjourned meeting on September 6, 2024, to determine if the remaining proposals are adopted.